Cargando…
Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study
BACKGROUND: The long-term safety and efficacy of fremanezumab were evaluated in a 52-week extension study (NCT02638103). Patient satisfaction with fremanezumab, dosing preferences, and patient-reported outcomes were assessed in a subpopulation who completed the extension study and consented to a fol...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487845/ https://www.ncbi.nlm.nih.gov/pubmed/32887548 http://dx.doi.org/10.1186/s10194-020-01177-4 |